Skip to content
The Policy VaultThe Policy Vault

Tiglutik KitMedical Mutual

Amyotrophic Lateral Sclerosis (ALS)

Preferred products

  • generic riluzole oral tablets

Initial criteria

  • Patient is age ≥ 18 years; AND
  • Baseline ALS Functional Rating Scale-Revised (ALSFRS-R) score measured; AND
  • Patient has normal respiratory function (defined as percent-predicted forced vital capacity values ≥ 60%); AND
  • Prescribed by or in consultation with a neurologist or physician who specializes in the treatment of ALS; AND
  • Patient must have previously tried therapy with generic riluzole oral tablets

Reauthorization criteria

  • Patient is age ≥ 18 years; AND
  • Baseline ALS Functional Rating Scale-Revised (ALSFRS-R) score measured; AND
  • Prescribed by or in consultation with a neurologist or physician who specializes in the treatment of ALS; AND
  • Patient must have previously tried therapy with generic riluzole oral tablets

Approval duration

initial 6 months; reauth 1 year